Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
470K
-
Shares change
-
+17.9K
-
Total reported value, excl. options
-
$1.4M
-
Value change
-
+$54.7K
-
Number of buys
-
4
-
Number of sells
-
-2
-
Price
-
$3.29
Significant Holders of Lexaria Bioscience Corp. - COM NEW (LEXX) as of Q1 2022
10 filings reported holding LEXX - Lexaria Bioscience Corp. - COM NEW as of Q1 2022.
Lexaria Bioscience Corp. - COM NEW (LEXX) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 470K shares
.
Largest 10 shareholders include Invenomic Capital Management LP (365K shares), GEODE CAPITAL MANAGEMENT, LLC (49K shares), VANGUARD GROUP INC (34.1K shares), Virtu Financial LLC (12K shares), Tower Research Capital LLC (TRC) (3.06K shares), 1832 Asset Management L.P. (2.69K shares), UBS Group AG (2.66K shares), WELLS FARGO & COMPANY/MN (1K shares), ROYAL BANK OF CANADA (283 shares), and Edge Wealth Management LLC (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.